Skip to content

Heart muscle disorder

Clinical and Genetic Evaluation of Cardiomyopathy - -

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/11/010532
Enrollment
200
Registered
2017-11-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Cardiomyopathy

Interventions

None listed

Sponsors

ICMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients previously diagnosed with cardiomyopathies or new presentation of cardiomyopathies based on 2D-echocardiogram and ECG reports

Exclusion criteria

Exclusion criteria: Patients with other structural abnormalities which leads to cardiomyopathies like valvular diseases and aortic stenosis

Design outcomes

Primary

MeasureTime frame
1. Identification of causal mutations of cardiomyopathies in local population 2. Genotype and phenotype correlationTimepoint: 3 years

Secondary

MeasureTime frame
Novel mutations in the local population and its characterizationTimepoint: 3 years

Countries

India

Contacts

Public ContactDrMRSekhar

Manipal University

prabodh2211@gmail.com9742056037

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026